0001437749-23-006105.txt : 20230310 0001437749-23-006105.hdr.sgml : 20230310 20230310113853 ACCESSION NUMBER: 0001437749-23-006105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230307 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kjems Lise Lund CENTRAL INDEX KEY: 0001884844 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39780 FILM NUMBER: 23722378 MAIL ADDRESS: STREET 1: 91 ROLLINGWOOD LN. CITY: CONCORD STATE: MA ZIP: 01742 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINESVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 4 1 rdgdoc.xml FORM 4 X0306 4 2023-03-07 0000922247 Cyclo Therapeutics, Inc. CYTH 0001884844 Kjems Lise Lund 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 1 Chief Medical Officer Stock Option (Right to buy) 1.28 2023-03-07 4 A 0 55453 0 A 2033-03-07 Common Stock 55453 55453 D The option vests over a four year period in equal monthly installments. /s/ Lise Lund Kjems 2023-03-08